Invasive Pulmonary Aspergillosis in Non-Neutropenic Patients: Analysis of a 14-Month Prospective Clinical Experience

REFERENCES

• Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006; 173: 707–717.
   PubMed Web of Science ®Google Scholar
• Meersseman W, VandecasteeleS J, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients with-out malignancy. Am J Respir Crit Care Med 2004; 170: 621–625.
   PubMed Web of Science ®Google Scholar
• Ader F, Nseir S, Le Berre R, Leroy S, Tillie-Leblond I, Marquette CH et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary dis-ease: an emerging fungal pathogen. Clin Microbiol Infect 2005; 11: 427–429.
   Google Scholar
• Falcone M, Massetti AP, Russo A, Vullo V, Venditti M. Invasive as-pergillosis in patients with liver disease. Med Mycol. 2011; 49: 406–13.
   PubMed Web of Science ®Google Scholar
• Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007; 30: 782–800.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infec-tions Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin In-fect Dis 2008; 46: 1813–1821.
   Google Scholar
• Comillet A, Camus C, Nimubona S Gandemer V, Tattevin P, Belleguic C et al. Comparison of epidemiological, clinical, and biological features of in-vasive aspergillosis in neutropenic and non-neutropenic patients: a 6-year survey. Clin Infect Dis 2006; 43: 577–584.
   Google Scholar
• Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an interna-tional consensus. Clin Infect Dis 2002; 34: 7–14.
   Google Scholar
• Walsh TJ, Shoham S, Petraitiene R, Sein T, Schaufele R, Kelaher A et al. Detection of galactomannan antigenemia in patients receiving piperacil-lin-tazobactam and correlations between in vitro, in vivo, and clinical pro-perties of the drug- antigen interaction. J Clin Microbiol 2004; 42: 4744–8.
   Google Scholar
• Cornet M, Mallat H, Somme D, Guérot E, Kac G, Mainardi JL et al. Fulminant invasive pulmonary aspergillosis in immunocompetent patients—a two-case report. Clin Microbiol Infect 2003; 9: 1224–7.
   Google Scholar
• Denning DW. Aspergillosis in “nonimmunocompromised” critically ill patients. Am J Respir Crit Care Med 2004; 170: 580–1.
   PubMed Web of Science ®Google Scholar
• Petri MG, Konig J, Moecke HP, Gramm HJ, Barkow H, Kujath P et al. Epidemiology of invasive mycosis in ICU patients: a prospective multi-center study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 1997; 23: 317–25.
   Google Scholar
• Peter E, Bakri F, Ball DM, Cheney RT, Segal BH. Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid ther-apy. Clin Infect Dis 2002; 35: e54–6.
   PubMed Web of Science ®Google Scholar
• Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 494–503.
   PubMed Web of Science ®Google Scholar
• Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. In-vasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26: 1473–5.
   PubMed Web of Science ®Google Scholar
• Carfagna P, Brandimarte F, Caccese R, Campagna D, Brandimarte C, Venditti M. Fatal Invasive Pulmonary Aspergillosis Complicating Influenza A (H1N1)v Infection. Mycoses, on line early, 2011
   Google Scholar
• Lichtner M, Mastroianni CM, Rossi R, Russo G, Belvisi V, Marocco R et al. Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 Infection. PLoS One. 2011; 6:e19872.
   Google Scholar
• Maris C, Martin B, Creteur J, Remmelink M, Piagnerelli M, Salmon I et al. Comparison of clinical and post-mortem findings in intensive care unit patients. Virchows Arch (2007) 450: 329–333.
   Google Scholar
• Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Van-derschueren S et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177: 27–34.
   PubMed Web of Science ®Google Scholar
• Nucci M, Nouér SA, Grazziutti M, Kumar NS, Barlogie B, Anaissie E. Probable invasive aspergillosis without prespecified radiologic findings: pro-posal for inclusion of a new category of aspergillosis and implications for studying novel therapies. Clin Infect Dis. 2010 1; 51: 1273–80
   Google Scholar
• Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, Pelàez T et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect. 2010; 16: 870–7
   Google Scholar
• Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007; 45: 205–216.
   PubMed Web of Science ®Google Scholar
• Kwak EJ, Husain S, Obman A, Meinke L, Stout J, Kusne S et al. Ef-ficacy of galactomannan antigen in the Platelia Aspergillus enzyme immu-noassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004; 42: 435–438.
   PubMed Web of Science ®Google Scholar
• Kimura SI, Odawara J, Aoki T, Yamakura M, Takeuchi M, Matsue K. Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients. Int J Hematol 2009; 90: 463–470.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327–360.
   PubMed Web of Science ®Google Scholar
• Crandon JL, Banevicius MA, Fang AF, Crownover PH, Knauft RF, Pope JS et al. Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults. Antimicrob Agents Chemother. 2009; 53: 5102–7.
   Google Scholar